Company Filing History:
Years Active: 2001
Title: **Innovations of John M. Crawford, Jr.**
Introduction
John M. Crawford, Jr. is an innovative inventor based in Raleigh, NC. He has significantly contributed to the field of biochemistry through his research and invention related to deoxylulose 5-phosphate synthase (DXPS). His expertise in this area has led to the development of methods that can greatly impact agricultural and microbial growth strategies.
Latest Patents
Crawford holds one patent titled "Methods for determining deoxyxylulose 5-phosphate synthase activity." This patent includes methods and compositions for determining DXPS activity, essential for understanding metabolic pathways in organisms. The invention emphasizes high-throughput screening assays which are vital for identifying inhibitors and enhancers of DXPS activity. These compounds can be instrumental in modulating plant and microbial growth. Additionally, the compositions outlined in the patent involve DXPS fragments and chimeric polypeptides that enhance solubility compared to the wild-type polypeptide, enabling efficient expression and purification for further assays.
Career Highlights
John M. Crawford, Jr. is associated with Paradigm Genetics, Inc., where he continues to drive advancements in genetic technology and agricultural development. His role at this innovative company allows him to collaborate with other skilled professionals in the field, expanding the breadth of his work.
Collaborations
Throughout his career, Crawford has collaborated with notable coworkers, including John W. Rice and Andreas S. Kloti. These partnerships have fostered an environment of creativity and technological advancement within the organization, helping to propel innovative solutions in biochemistry and beyond.
Conclusion
John M. Crawford, Jr. exemplifies the spirit of innovation in the scientific community. His contributions, particularly through his patent on DXPS activity, showcase the potential for developing new methods that can aid in agricultural and microbial advancements. As he continues to work with Paradigm Genetics, Inc. and within his professional collaborations, his impact on the field is likely to grow, paving the way for future innovations.